ROR-2 inhibitor (Kancera)

N/A

Report date: 2025/03/20 09:40:35
NME

Base Information

Drug NameROR-2 inhibitor (Kancera)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase transmembrane receptor ROR2 inhibitors
TargetsTyrosine-protein kinase transmembrane receptor ROR2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKancera AB
China Registration ClassN/A

Develop Information

Active CompaniesKancera AB
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A